The OHSU Knight Cancer Institute is a pioneer in personalized cancer treatment and research, led by Dr. Brian Druker, whose development of Gleevec transformed Chronic Myeloid Leukemia from a fatal disease to a manageable one and proved that targeted therapies can work. The institute focuses on precision oncology, the early detection, prevention, and treatment of cancer, and creating a welcoming and supportive environment for its caregivers, researchers, and support personnel. Knight affiliates subscribe to three guiding principles: we are bold, we are supportive, and we work as a connected team in our fight to end cancer as we know it. We¿d love for you to join us!
Cancer Early Detection Advanced Research Center (CEDAR) is a highly collaborative institution within the OHSU Knight Cancer Institute. At CEDAR our mission is to detect and stop lethal cancers at the earliest stage because early detection saves lives. This is an ambitious goal, one that requires novelty, creativity, and innovation. We conduct groundbreaking translational cancer research to help people maintain a high quality of life and reduce cancer mortality, to create a global early detection community, and to have a positive impact on the Oregon economy. Our clinical trials are cutting edge and laser focus on the exciting and rapidly evolving area of cancer early detection.
CEDAR is committed to increasing the diversity of the campus community. We are dedicated to promoting inclusion and multiculturalism to build a successful organization by having outstanding researchers of diverse backgrounds work together.
Every Knight Cancer employee is expected to embody our guiding principles:
CEDAR is hiring a Non-OHSU Student Worker to assist with Clinical Trials work, under supervision. This is not a summer-only position. Duties include:
Apply online. Please be sure to upload a Cover Letter and Resume/CV.
#knightinternal
Software Powered by iCIMS
www.icims.com